Cameco Stock Today: CCJ Holds $118 as Analysts Target $143 Amid Nuclear Energy Surge

Cameco stock today is trading near $118.11, down just 0.06% intraday, as investors continue evaluating the uranium leader’s position in the accelerating global nuclear build-out. With Wall Street’s average price target near $143.03, the question dominating searches is straightforward: can CCJ extend its multi-year rally?

At current levels, Cameco Corporation (NYSE: CCJ) commands a market capitalization of approximately $51.48 billion. The stock opened around $116.20 and has traded between $116.00 and $119.17 during the session, reflecting tight consolidation near recent highs.

Valuation Snapshot

Investors paying attention to fundamentals will notice that CCJ is trading at a premium multiple:

• Trailing P/E Ratio: 120.53
• EPS (TTM): $0.98
• Beta (5Y Monthly): 1.10
• Quick Ratio: 1.68
• Current Ratio: 2.47
• Debt-to-Equity: 0.14
• Forward Dividend: $0.17 (0.15% yield)

The elevated earnings multiple reflects forward expectations rather than current profitability. The market is pricing in continued strength in uranium contracting, long-term supply agreements, and tightening global inventories.

Institutional Positioning Remains Strong

Roughly 70.21% of CCJ shares are held by institutions and hedge funds. Recent filings show mixed but constructive positioning:

• Primecap Management reduced its stake by 8.3% but still holds over 1.03 million shares valued near $86.9 million.
• Mirae Asset Global Investments increased its position by 79.4%.
• Hillsdale Investment Management boosted exposure by over 165% in a prior quarter.

Large funds trimming into strength while maintaining sizable exposure is typically portfolio rebalancing rather than a structural exit from the uranium thesis.

Recent Earnings Beat Expectations

Cameco’s latest quarterly results reinforced operational stability:

• EPS: $0.36 vs. $0.29 consensus
• Revenue: $874.57 million vs. $782.13 million expected
• Net Margin: 17.00%
• Return on Equity: 9.35%

Full-year earnings are projected around $1.27 per share, indicating improving leverage to uranium contract pricing.

Nuclear Boom Driving the Narrative

The broader investment case centers on rising electricity demand driven by AI data centers, decarbonization mandates, and geopolitical energy security concerns. Nuclear energy provides reliable baseload power, positioning uranium suppliers strategically within global energy policy.

For deeper context on global uranium markets and contracting trends, the World Nuclear Association provides detailed data on uranium supply and market fundamentals.

Cameco operates major assets in Canada and the United States, supplying utilities through long-term agreements as well as selective spot exposure — helping smooth volatility during commodity cycles.

Technical Structure

From a trading perspective:

• 52-Week Range: $35.00 – $135.24
• Stock is trading above its 50-day average (~$111)
• Major resistance remains near $130-$135
• Support zone developing around $115

The stock has rallied dramatically from last year’s $35 lows, meaning volatility should be expected as momentum consolidates.

Analyst Ratings and Price Targets

According to compiled research:

• 1 Strong Buy rating
• 13 Buy ratings
• 2 Hold ratings
• Consensus: Moderate Buy
• Average Price Target: $143.03

From current levels near $118, the consensus implies roughly 20% upside potential, though valuation sensitivity remains high if uranium prices cool.

Risks to Watch

• Uranium price volatility
• Political and regulatory shifts in nuclear policy
• Execution risks in production ramp-ups
• High valuation relative to trailing earnings

Given its premium multiple, CCJ is more sensitive to sentiment shifts than traditional low-P/E energy stocks.

Bottom Line

Cameco stock today is stabilizing near $118 after an extraordinary multi-year run. Institutional ownership remains high, earnings have beaten expectations, and analysts continue targeting the $140 area. However, much of the nuclear boom optimism is already reflected in the price.

For investors seeking exposure to the uranium theme, CCJ remains a core industry leader — but entry timing and commodity discipline will likely define returns in 2026.